(lp0
S'Why Progenics Pharmaceuticals, Inc. Stock Climbed 76.5% in November Motley Fool - Dec 6, 2016 Shares of Progenics Pharmaceuticals, Inc. , a small biotech with an oncology focus, rocketed up 76.5% in November, according to data from S&amp;P Global Market Intelligence.'
p1
aS"Progenics Pharmaceuticals, Inc. to Participate in February Investor Conferences GlobeNewswire  - Feb 8, 2017 NEW YORK, Feb. 08, 2017  -- Progenics Pharmaceuticals, Inc. , an oncology company developing innovative medicines and other technologies for targeting and treating cancer, today announced that Mark Baker, Chief&nbsp;...Noticeable Analyst's Ideas: Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX ... - TRALarge Buying Action and Inflow of Money Witnessed in Progenics Pharmaceuticals ... - Highland Mirror"
p2
aS"Why Progenics Pharmaceuticals, Inc. Is Rising Today Motley Fool - Oct 4, 2016 It certainly is an exciting time to be an investor in Progenics. The company and its partner Valeant Pharmaceuticals  just launched an oral version of their opioid-induced constipation  drug Relistor in the third quarter. While the drug ...Brean Capital Assumes Buy on Progenics Pharmaceuticals, Inc. ; Sees 50 ... - Smarter AnalystProgenics Pharma : Profitability Could Come In '17 - Needham - StreetInsider.com"
p3
aS'Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2016 ... Yahoo Finance - Mar 9, 2017 NEW YORK, March 09, 2017  -- Progenics Pharmaceuticals, Inc.  today announced financial results and provided a business update for the fourth quarter and full-year 2016.'
p4
aS'Progenics Pharmaceuticals Inc.  Breaks into New 52-Week High on March 15 ... Equities.com - Mar 15, 2017 Shares of Progenics Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $11.72. Shares closed at $11.60 after opening at $11.25 for a move of 3.39%.Analysts Set Progenics Pharmaceuticals, Inc.  Target Price at $11.60 - Chaffey BreezeThe Progenics Pharmaceuticals, Inc.  Expected to Post Q1 2017 Earnings ... - Petro Global News 24'
p5
aS'Progenics Pharmaceuticals Sets Fourth Quarter and Year-End 2016 Financial ... GlobeNewswire  - Feb 23, 2017 NEW YORK, Feb. 23, 2017  -- Progenics Pharmaceuticals, Inc., , an oncology company developing innovative medicines and other products for targeting and treating cancer, announced today that it will host a conference&nbsp;...Stock Price of Progenics Pharmaceuticals Inc.  Increases 11.56% - Energy IndexHighly Traded Stock: Progenics Pharmaceuticals, Inc.  - HugoPress'
p6
aS'Price Alert: Progenics Pharmaceuticals Inc  Stock Approaches ... CML News - 21 hours ago Price Alert: Progenics Pharmaceuticals Inc  has now crossed into technical strength -- watch the technical oscillators for momentum gaps.'
p7
aS'With An ROE OF 10.4% In The Past Year, Can Progenics Pharmaceuticals Inc (PGNX ... Simply Wall St - Mar 6, 2017 Progenics Pharmaceuticals Inc  delivered 10.4% ROE over the past year, compared to 27.38% generated by its industry.Rating Change on Progenics Pharmaceuticals Inc.  - Energy IndexInvestors Reviewing Stock: Progenics Pharmaceuticals Inc.  - Is stories'
p8
aS'Progenics Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 16 Equities.com - Feb 16, 2017 Progenics Pharmaceuticals Inc.  traded on unusually high volume on Feb. 16, as the stock gained 9.56% to close at $10.54.Oxford Asset Management Buys New Position in Progenics Pharmaceuticals Inc.  - BNB Daily Trending Stocks: McEwen Mining Inc. , Progenics Pharmaceuticals, Inc ... - TRA'
p9
aS'Progenics Pharmaceuticals  in Focus: Stock Gains 8.3% Yahoo Finance - Feb 28, 2017 Progenics Pharmaceuticals PGNX was a big mover last session, as the company saw its shares rise above 8% on the day.Progenics Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 28 - Equities.comShares of Progenics Pharmaceuticals Inc.  Plunge -2.45% - Energy Index'
p10
a.